Vetmedin 1.25 mg capsules
Negara: Irlandia
Bahasa: Inggris
Sumber: HPRA (Health Products Regulatory Authority)
Karakteristik produk
(SPC)
15-05-2024
Beberapa dokumen untuk produk ini saat ini tidak tersedia, Anda dapat mengirim permintaan ke layanan pelanggan kami dan kami akan memberi tahu Anda segera setelah kami bisa mendapatkannya.
Kirim permintaan.
Kirim permintaan.
Bahan aktif:
pimobendan
Tersedia dari:
Boehringer Ingelheim Ltd
Kode ATC:
QC01CE90
Dosis:
1.25 Milligram
Bentuk farmasi:
Capsules Hard
Kelompok Terapi:
Canine
Area terapi:
Cardiovascular
Status otorisasi:
Authorised
Karakteristik produk
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Vetmedin 1.25 mg capsules.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains:
Active Substance
Pimobendan
1.25 mg
Excipients
Titanium Dioxide (E171)
0.976 mg
Ferric Oxide Yellow (E172)
0.0439 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Capsule, hard and yellow/white in colour
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dog.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of canine congestive heart failure originating from valvular insufficiency (mitral and/or tricuspid
regurgitation) or dilated cardiomyopathy.
When used in cases of valvular insufficiency in conjunction with frusemide, the product has been shown to improve the
quality of life and extend life expectancy in treated dogs.
When used in a limited number of cases of dilated cardiomyopathy in large breed dogs in conjunction with concomitant
standard therapy, the product has been shown to improve the quality of life and to extend life expectancy in treated dogs.
4.3 CONTRAINDICATIONS
Vetmedin capsules should not be used in cases of hypertrophic cardiomyopathies or clinical conditions where an
augmentation of cardiac output is not possible for functional or anatomical reasons (e.g. aortic stenosis).
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 26/08/2013_
_CRN 7015504_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
This product should be used only in dogs with cardiac insufficiency.
Do not exceed the recommend dosage.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT T
Baca dokumen lengkapnya
